ARTHEx Biotech Announces Oral Presentation on ATX-01 at the Oligonucleotide & Peptide Therapeutics (TIDES) Conference 2024

/PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs,...

Related Keywords

Boston ,Massachusetts ,United States ,Juniper Point ,Spain ,Valencia ,Carabobo ,Venezuela ,Amy Conrad ,Company Contact ,Linkedin ,Peptide Therapeutics ,Biotech Executive Chairman ,Skeletal Muscle ,Nervous System ,Dual Therapeutic Approach ,Oligonucleotide Discovery ,Orphan Drug Designation ,Myotonic Dystrophy Type ,Arthex Biotech ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Clinical Trials Amp Medical Discoveries ,